Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daniel Wilkinson
Institution:
University of Colorado Anschutz
Observed institution:
University of Colorado Anschutz
ORCID:
0000-0001-9619-6914
Observed ORCID:
0000-0001-9619-6914
OpenAlex ID:
A5132865913
Tlsb-21 Intracranial Tumors (primary or Metastatic) Elicit Systemic Sympathetic Hyperactivity That Induces Systemic Immune Dysfunction and Limits Immunotherapeutic Success
2026
·
Peter Fecci
, Daniel Wilkinson
, et al.
·
Neuro-Oncology Advances
PDF
Tlsb-20 Car T Cells Engineered With Bispecific Engagers Without Antigen Requirements (care-bear) Sidesteps Tumor Heterogeneity and Kills Solid Tumors in Histology-agnostic Fashion
2026
·
Peter Fecci
, Daniel Wilkinson
, et al.
·
Neuro-Oncology Advances
Abstract 3166: TKI adaptive resistance in HER2-driven non-small cell lung cancer at minimal residual disease stage can be targeted using cell surface-directed therapies
2026
·
Manale El Kharbili
, Daniel Wilkinson
, et al.
·
Cancer Research
Supplementary Table 2 from Upregulation of TNFR2 Precedes TOX Expression by Exhausted T cells and Restricts Antitumor and Antiviral Immunity
2026
·
Alexandra M. Hoyt-Miggelbrink
, Jessica Waibl Polania
, et al.
Data from Upregulation of TNFR2 Precedes TOX Expression by Exhausted T cells and Restricts Antitumor and Antiviral Immunity
2026
·
Alexandra M. Hoyt-Miggelbrink
, Jessica Waibl Polania
, et al.
Show more works
View as search
Works count:
5
Citation count:
H-index:
I10-index:
Year
Topic
Type